Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...

Engineered extracellular vesicles delivering full-length DMD mRNA restored dystrophin and improved muscle strength and ...

The battle against the most dangerous type of skin cancer has made a huge leap forward, and it could dramatically change the ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

Researchers are particularly encouraged by new data involving a personalized mRNA therapy developed by Moderna and Merck.

In the phase 2b KEYNOTE-942 trial, researchers studied 157 patients with stage III or IV melanoma who had undergone surgery ...

A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver ...

Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

Although Moderna has outperformed the broader health care sector over the last 12 months, analysts maintain a cautious stance ...